Supplementary Table 3 from Allelic Transcripts Dosage Effect in Morphologically Normal Ovarian Cells from Heterozygous Carriers of a &lt;i&gt;BRCA1&lt;/i&gt;/&lt;i&gt;2&lt;/i&gt; French Canadian Founder Mutation